Skip to content

Observation on the effect of auricular point pressing pill on sleep disorder after general anesthesia operation based on Chinese medicine constitution identification

Observation on the effect of auricular point pressing pill on sleep disorder after general anesthesia operation based on Chinese medicine constitution identification

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065846
Enrollment
Unknown
Registered
2022-11-16
Start date
2022-07-05
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative sleep disturbance

Interventions

Control group:ear auricular point pressing pill
Intervention group:Ear point pressing pills according to system identification results

Sponsors

Guangdong Provincial Hospital of Chinese Medicine (The Second Affiliated Hospital of Guangzhou University of Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. The patients who planned to perform endoscopic thyroid surgery under general anesthesia; 2. Age 18-75 years; 3. Body Mass Index (BMI) 18-30 kg/m2; 4. ASA (American Standards Association) is classified as Grade I to Grade III; 5. Sign the informed consent form voluntarily.

Exclusion criteria

Exclusion criteria: 1. People with sleep disorders and mental disorders in the past, those who take sleeping pills, sedatives, antidepressants and hormones for a long time before surgery, or other drug abusers or alcoholics; 2. According to the Constitution Classification and Judgment Table of Traditional Chinese Medicine, those who are judged as peaceful; 3. History of serious cardiovascular and cerebrovascular diseases; 4. There is local skin damage, infection or implantation of electrophysiological devices in the body; 5. Those who do not agree with the author or have severe visual or hearing impairment or inability to communicate; 6. Participants in other clinical trials within 3 months before inclusion in the study.

Design outcomes

Primary

MeasureTime frame
Insomnia Severity Index Scale, ISI;Pittsburgh sleep quality index scale;

Secondary

MeasureTime frame
Visual Analogue Scale to Evaluate Fatigue Severity, VAS-F;Identity-Consequence Fatigue Scale, ICFS;Visual Analogue Scale;Nausea and vomiting;Total serum protein, TP;Serum Albumin, ALB;Serum prealbumin, PA;C-reactive protein, CRP;

Countries

China

Contacts

Public ContactDeng Jiemin

Guangdong Provincial Hospital of Chinese Medicine (The Second Affiliated Hospital of Guangzhou University of Chinese Medicine)

michi_tang@163.com+86 13763384450

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026